Aromatase inhibitor and tamoxifen use and the risk of venous thromboembolism in breast cancer survivors
2019; Springer Science+Business Media; Volume: 174; Issue: 3 Linguagem: Inglês
10.1007/s10549-018-05086-8
ISSN1573-7217
AutoresXiaoqing Xu, Rowan T. Chlebowski, Jiaxiao Shi, Ana Barac, Reina Haque,
Tópico(s)Chemotherapy-induced cardiotoxicity and mitigation
Referência(s)